中国医药导报
中国医药期刊欢迎您 今天是   2025年4月16日星期三
设为首页 | 加入收藏 
 
        首 页      期刊介绍      下载中心      关于本刊      投稿指南      期刊订阅      在线留言      广告合作      联系我们      返回中国当代医药网
中国医药导报
  临床医学-心血管疾病 本期目录 | 过刊浏览 | 高级检索 |
心痛泰颗粒治疗气滞血瘀证稳定型心绞痛的效果及对心肌能量代谢的影响
李佳玲      魏佳明      李玉莹      唐云      李雅      郭志华
湖南中医药大学第一中医临床学院,湖南长沙   410208
Effect of Xintongtai Granules in treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis and influence on myocardial energy metabolism
LI Jialing   WEI Jiaming   LI Yuying   TANG Yun   LI Ya   GUO Zhihua
The First Clinical College of Traditional Chinese Medicine, Hu’nan University of Chinese Medicine, Hu’nan Province, Changsha   410208, China
全文: PDF (597 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨心痛泰颗粒治疗气滞血瘀证稳定型心绞痛的临床效果及对患者心肌能量代谢的影响。 方法 选取2018年6月—2020年6月湖南中医药大学第一附属医院和湖南中医药大学第二附属医院门诊及住院部收治的气滞血瘀证稳定型心绞痛患者60例,按照随机数字表法将其分为观察组和对照组,每组各30例。观察组采用心痛泰颗粒联合西医规范治疗,对照组采用盐酸曲美他嗪联合西医规范治疗。治疗4周后,评价两组临床疗效,并于治疗前后检测两组心肌能量消耗水平和血清游离脂肪酸含量。 结果 观察组心绞痛、心电图疗效的总有效率高于对照组,差异均统计学意义(均P < 0.05)。观察组停减率高于对照组,差异有统计学意义(P < 0.05)。治疗后两组心肌能量消耗水平、血清游离脂肪酸含量均较治疗前降低,且观察组低于对照组,差异均有统计学意义(均P < 0.05)。 结论 心痛泰颗粒联合西医规范治疗运用于气滞血瘀证稳定型心绞痛临床治疗效果显著,其作用机制可能与心肌能量消耗水平和血清游离脂肪酸含量降低有关。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
李佳玲 魏佳明 李玉莹 唐云 李雅 郭志华
关键词 心痛泰颗粒稳定型心绞痛气滞血瘀证心肌能量消耗游离脂肪酸    
Abstract:Objective To investigate the clinical effect of Xingtongtai Granules in the treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis and influence on myocardial energy metabolism of patients. Methods A total of 60 patients with stable angina pectoris with syndrome of qi stagnation and blood stasis treated in the outpatient department and inpatient department of the First Hospital Hu’nan University of Chinese Medicine and the Second Affiliated Hospital of Hu’nan University of Chinese Medicine from June 2018 to June 2020 were selected and they were divided into observation group and control group according to random number table method, with 30 patients in each group. The observation group was treated with Xintongtai Granules combined with Western medicine standard treatment, while the control group was treated with Trimetazidine Hydrochloride combined with Western medicine standard treatment. After four weeks of treatment, the clinical efficacy of the two groups was evaluated, and myocardial energy expenditure level and serum free fatty acids content were detected before and after treatment. Results The total effective rate of angina pectoris and electrocardiogram in the observation group was higher than that in the control group, and the differences were statistically significant (all P < 0.05). The stopping rate of observation group was higher than control group, and the difference was statistically significant (P < 0.05). After treatment, myocardial energy expenditure level and serum free fatty acids content in both groups were lower than those before treatment, and observation group was lower than control group, the differences were statistically significant (all P < 0.05). Conclusion Xintongtai Granules combined with Western medicine standard treatment has a significant clinical effect in the treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis, the mechanism of which may be related to the decrease of myocardial energy expenditure level and serum free fatty acids content.
Key wordsXintongtai Granules    Stable angina pectoris    Syndrome of qi stagnation and blood stasis    Myocardial energy expenditure    Free fatty acids
    
基金资助:国家自然科学基金资助项目(81673955);湖
南中医药大学中医学一流学科开放基金项目(2018ZYX43)。
通讯作者: 郭志华(1964-),男,博士,主任医师,教授,博士生导师;研究方向:中医心血管疾病。   
作者简介: 李佳玲(1995-),女,湖南中医药大学第一中医临床学院2018级中医内科学专业在读硕士研究生;研究方向:中医心血管疾病。
引用本文:   
李佳玲 魏佳明 李玉莹 唐云 李雅 郭志华. 心痛泰颗粒治疗气滞血瘀证稳定型心绞痛的效果及对心肌能量代谢的影响[J]. 中国医药导报, 2021, 18(11): 62-65.
LI Jialing WEI Jiaming LI Yuying TANG Yun LI Ya GUO Zhihua. Effect of Xintongtai Granules in treatment of stable angina pectoris with syndrome of qi stagnation and blood stasis and influence on myocardial energy metabolism. 中国医药导报, 2021, 18(11): 62-65.
链接本文:  
https://www.yiyaodaobao.com.cn/CN/     或     https://www.yiyaodaobao.com.cn/CN/Y2021/V18/I11/62

 

中华人民共和国互联网药品信息服务资格证书(京)-非经营性-2016-0092
京ICP11001767号-2  京公网安备 11010502046598号  期刊出版许可证 广告经营许可证
信息产业部备案管理系统网址 http://beian.miit.gov.cn/state/outPortal/loginPortal.action
投稿热线:010-59626203
本刊地址:北京市朝阳区东四环中路78号楼(大成国际中心B1座)8B02室 邮编:100124
传真:010-59626204 投稿信箱:ddyy@vip.163.com
版权所有:中文传媒集团北京期刊有限公司
技术支持:北京玛格泰克科技发展有限公司